NZpharma
ActiveSummary
The computed 12-month bankruptcy probability of NZpharma is 2.9% (moderate). The 2025 annual accounts show equity of €65k and a net result of €24k. Equity is growing by ~69.7% per year across the filed fiscal years. Its solvency ranks better than 92% of 18400 sector peers (fiscal year 2025). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
Axes · tick = 2024
Profitability100=
Solvency100▲+16
Growth78=
Track record82
Bankruptcy probability, 12 months
2.9%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €5k at 30 days acceptable
Liquidity ample (current ratio 7.13 against 2.11 in 2024; short-term debt: 12.4% and cash: 76.3% of total assets), and 12.4% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
87.6%
Return on assets
32.2%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-09-2026, 41 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 3 filingsDeviation from the deadline
2025
41 d late
2024
60 d late
2023
153 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€65k▲ 58.1%
2024 · €41k
2023: €8klowest in 3 years
2024: €41k▲ +435% vs 2023
2025: €65k▲ +58.1% vs 2024highest in 3 years
2023 → 2025
Total assets
€74k▲ 7.3%
2024 · €69k
2023: €19klowest in 3 years
2024: €69k▲ +259% vs 2023
2025: €74k▲ +7.3% vs 2024highest in 3 years
2023 → 2025
Net result
€24k▼ 28.6%
2024 · €33k
2023: €5klowest in 3 years
2024: €33k▲ +614% vs 2023highest in 3 years
2025: €24k▼ -28.6% vs 2024
2023 → 2025
Working capital
€56k▲ 81.3%
2024 · €31k
2023: €8klowest in 3 years
2024: €31k▲ +305% vs 2023
2025: €56k▲ +81.3% vs 2024highest in 3 years
2023 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202320242025Trend
Equity€8k-€41k▲ 435%€65k▲ 58.1%
2023: €8klowest in 3 years
2024: €41k▲ +435% vs 2023
2025: €65k▲ +58.1% vs 2024highest in 3 years
Operating result€6k-€43k▲ 590%€31k▼ 28.0%
2023: €6klowest in 3 years
2024: €43k▲ +590% vs 2023highest in 3 years
2025: €31k▼ -28.0% vs 2024
Net result€5k-€33k▲ 614%€24k▼ 28.6%
2023: €5klowest in 3 years
2024: €33k▲ +614% vs 2023highest in 3 years
2025: €24k▼ -28.6% vs 2024
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 28% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €74k
Fixed assets
€9k ▼ 14.2%
Current assets
€66k ▲ 11.0%
Equity and liabilities €74k
Equity
€65k ▲ 58.1%
Debt
€9k ▼ 67.1%
Debt's share of the balance-sheet total falls from 40.5% to 12.4%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€34k▼
2024 · €45k
Cash flow
€26k▼
2024 · €35k
Current ratio
7.13▲
2024 · 2.11
Debt to equity
0.14▼
2024 · 0.68
ROE
36.7%▼
2024 · 81.3%
ROA
32.2%▼
2024 · 48.4%
Interest coverage
25.11▼
2024 · 32.97
Debt ≤ 1 year
€9k▼
2024 · €28k
Income taxes
€6k▼
2024 · €9k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 33 lines
Balance sheet
Code20242025
Assets
Total assets20/58€69k€74k▲
Fixed assets21/28€10k€9k▼
Tangible fixed assets22/27€10k€9k▼
Leasing and similar rights25€10k€9k▼
Current assets29/58€59k€66k▲
Amounts receivable within one year40/41€12k€9k▼
Trade receivables40€12k€9k▼
Cash at bank and in hand54/58€48k€57k▲
Equity and liabilities
Total equity and liabilities10/49€69k€74k▲
Equity10/15€41k€65k▲
Contributions10/11€3k€3k=
Profit (loss) carried forward14€38k€62k▲
Amounts payable17/49€28k€9k▼
Amounts payable within one year42/48€28k€9k▼
Trade debts44€13k€2k▼
Suppliers440/4€13k€2k▼
Taxes, remuneration and social security45€14k€8k▼
Taxes450/3€14k€8k▼
Other amounts payable47/48€1k-
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1k€3k▲
Other operating charges640/8-€400
Gross operating margin9900€45k€34k▼
Operating profit (loss)9901€43k€31k▼
Financial income75/76B-€263
Recurring financial income75-€263
Financial charges65/66B€1k€1k▼
Recurring financial charges65€1k€1k▼
Profit (loss) for the period before taxes9903€42k€30k▼
Income taxes67/77€9k€6k▼
Profit (loss) for the period9904€33k€24k▼
Profit (loss) for the period to be appropriated9905€33k€24k▼
Appropriation of the result
Profit (loss) to be appropriated9906€38k€62k▲
Profit (loss) brought forward from the previous period14P€5k€38k▲
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Goods, raw materials, services and sundry goods60/61 | €8k | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | - | €1k | €3k | ▲ 101% |
| Other operating charges640/8 | - | - | €400 | - |
| Gross operating margin9900 | €6k | €45k | €34k | ▼ 23.5% |
| Operating profit (loss)9901 | €6k | €43k | €31k | ▼ 28.0% |
| Financial income75/76B | - | - | €263 | - |
| Recurring financial income75 | - | - | €263 | - |
| Financial charges65/66B | €3 | €1k | €1k | ▼ 0.7% |
| Recurring financial charges65 | €3 | €1k | €1k | ▼ 0.7% |
| Profit (loss) for the period before taxes9903 | €6k | €42k | €30k | ▼ 28.2% |
| Income taxes67/77 | €2k | €9k | €6k | ▼ 26.9% |
| Profit (loss) for the period9904 | €5k | €33k | €24k | ▼ 28.6% |
| Profit (loss) for the period to be appropriated9905 | €5k | €33k | €24k | ▼ 28.6% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Assets | ||||
| Total assets20/58 | €19k | €69k | €74k | ▲ 7.3% |
| Fixed assets21/28 | - | €10k | €9k | ▼ 14.2% |
| Tangible fixed assets22/27 | - | €10k | €9k | ▼ 14.2% |
| Leasing and similar rights25 | - | €10k | €9k | ▼ 14.2% |
| Current assets29/58 | €19k | €59k | €66k | ▲ 11.0% |
| Amounts receivable within one year40/41 | €8k | €12k | €9k | ▼ 21.5% |
| Trade receivables40 | €8k | €12k | €9k | ▼ 21.5% |
| Cash at bank and in hand54/58 | €11k | €48k | €57k | ▲ 18.9% |
| Equity and liabilities | ||||
| Total equity and liabilities10/49 | €19k | €69k | €74k | ▲ 7.3% |
| Equity10/15 | €8k | €41k | €65k | ▲ 58.1% |
| Contributions10/11 | €3k | €3k | €3k | = |
| Profit (loss) carried forward14 | €5k | €38k | €62k | ▲ 62.7% |
| Amounts payable17/49 | €12k | €28k | €9k | ▼ 67.1% |
| Amounts payable within one year42/48 | €12k | €28k | €9k | ▼ 67.1% |
| Trade debts44 | €4 | €13k | €2k | ▼ 87.5% |
| Suppliers440/4 | €4 | €13k | €2k | ▼ 87.5% |
| Taxes, remuneration and social security45 | €7k | €14k | €8k | ▼ 44.9% |
| Taxes450/3 | €4k | €14k | €8k | ▼ 44.9% |
| Remuneration and social security454/9 | €3k | - | - | - |
| Other amounts payable47/48 | €5k | €1k | - | - |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Profit (loss) for the period9904 | €5k | €33k | €24k | ▼ 28.6% |
| + Depreciation and write-downs630 | - | €1k | €3k | ▲ 101% |
| Operating cash flow (approximation) | €5k | €35k | €26k | ▼ 23.9% |
| Investment in fixed assets (approximation) | - | - | €-1k | - |
| Change in cash | - | €37k | €9k | ▼ 75.6% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
10-09
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 41 days late
2025
31-12
Financial
Liquidity triplescurrent ratio 7.13
Current ratio from 2.11 to 7.13; short-term debt falls from €28k to €9k.
29-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 60 days late
2024
31-12
Financial
Highest result since 2023net €33k ▲614%
Operating result €43k, net result €33k, both a record.
31-12
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 153 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Lambrechts-Woluwe · 1 establishment unit since 2023
Ground area
6,440 m²
Building footprint
2,094 m²
Volume, LiDAR
57,264 m³
Parcel 21018A0008/00K000, Brussels · tallest building 32.7 m, ±9 floors. Linked by address, not a title deed.
13
companies at this address
See who is registered here
1 establishment unit
NZpharma
since 20232.355.757.242
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21018A0008/00K000 | Brussels | 6,440 m² | 1 · 2,094 m² | 32.7 m · 9 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
PHARMACIE VR
BE 0681.431.631
Quiévrain · Eq €65,106
Apotheek Vandenabeele
BE 0794.880.653
Antwerpen · Eq €65,209
APOTHEEK COPPENS-DERCON
BE 0836.902.043
Antwerpen · Eq €64,695
NATHYPHARM
BE 0837.507.106
Andenne · Eq €65,374
POELMAN
BE 0428.334.479
Tessenderlo-Ham · Eq €65,390
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,054 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded17-11-2023
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
47750Retail sale of cosmetics and toilet articles
Scores and ratios are computed by Checked and are not a credit decision.